Impact of diabetes (type 2) and glycemic control on health-related outcomes of patients receiving chemotherapy for non-metastatic breast cancer: a retrospective analysis
Author:
Funder
Oncology Nursing Foundation
American Cancer Society
Melvin and Bren Simon Cancer Center, Indiana University
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
https://link.springer.com/content/pdf/10.1007/s00520-022-07563-9.pdf
Reference30 articles.
1. Giovannucci E, Harlan DM, Archer MC et al (2010) Diabetes and cancer: a consensus report. CA Cancer J Clin 60(4):207–221. https://doi.org/10.3322/caac.20078
2. Peairs KS, Barone BB, Snyder CF et al (2011) Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J Clin Oncol 29(1):40–46. https://doi.org/10.1200/JCO.2009.27.3011
3. Center for Disease Control and Prevention (2022) National diabetes statistics report: estimates of diabetes and its burden in the United States. Retrieved from https://www.cdc.gov/diabetes/data/statistics-report/index.html. Accessed July 2022
4. Zhao XB, Ren GS (2016) Diabetes mellitus and prognosis in women with breast cancer: a systematic review and meta-analysis. Medicine (Baltimore) 95(49):e5602. https://doi.org/10.1097/MD.0000000000005602
5. Shao S, Gill AA, Zahm SH et al (2018) Diabetes and overall survival among breast cancer patients in the US military health system. Cancer Epidemiol Biomarkers Prev 27(1):50–57. https://doi.org/10.1158/1055-9965.EPI-17-0439
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view;Journal of Endocrinological Investigation;2024-06-27
2. Application of neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy in curative surgery for esophageal cancer: A meta-analysis;World Journal of Gastrointestinal Oncology;2024-01-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3